These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 8600511)

  • 1. Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb.
    Brenner DJ
    Radiat Res; 1996 Apr; 145(4):501-7. PubMed ID: 8600511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima.
    Kodama Y; Ohtaki K; Awa AA; Nakano M; Itoh M; Nakamura N
    Radiat Res; 1999 Nov; 152(5):558-62. PubMed ID: 10521934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable chromosome aberrations among A-bomb survivors: an update.
    Stram DO; Sposto R; Preston D; Abrahamson S; Honda T; Awa AA
    Radiat Res; 1993 Oct; 136(1):29-36. PubMed ID: 8210335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M; Schull WJ
    Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological effectiveness of neutrons from Hiroshima bomb replica: results of a collaborative cytogenetic study.
    Dobson RL; Straume T; Carrano AV; Minkler JL; Deaven LL; Littlefield LG; Awa AA
    Radiat Res; 1991 Nov; 128(2):143-9. PubMed ID: 1947011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
    Rühm W; Walsh L; Chomentowski M
    Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrons at Hiroshima: how their disappearance affected risk estimates.
    Ellett WH
    Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental derivation of relative biological effectiveness of A-bomb neutrons in Hiroshima and Nagasaki and implications for risk assessment.
    Sasaki MS; Nomura T; Ejima Y; Utsumi H; Endo S; Saito I; Itoh T; Hoshi M
    Radiat Res; 2008 Jul; 170(1):101-17. PubMed ID: 18582156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
    Hunter N; Charles MW
    J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons.
    Sasaki MS; Endo S; Ejima Y; Saito I; Okamura K; Oka Y; Hoshi M
    Radiat Environ Biophys; 2006 Jul; 45(2):79-91. PubMed ID: 16807767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 1. Comparison of risk coefficients for site-specific cancer mortality based on the DS86 and T65DR shielded kerma and organ doses.
    Shimizu Y; Kato H; Schull WJ; Preston DL; Fujita S; Pierce DA
    Radiat Res; 1989 Jun; 118(3):502-24. PubMed ID: 2727272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current risk estimates based on the A-bomb survivors data - a discussion in terms of the ICRP recommendations on the neutron weighting factor.
    Rühm W; Walsh L
    Radiat Prot Dosimetry; 2007; 126(1-4):423-31. PubMed ID: 17533156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors.
    Kellerer AM; Rühm W; Walsh L
    Health Phys; 2006 Jun; 90(6):554-64. PubMed ID: 16691103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of gamma and neutron radiation to posterior lenticular opacities among atomic bomb survivors in Hiroshima and Nagasaki.
    Otake M; Schull WJ
    Radiat Res; 1982 Dec; 92(3):574-95. PubMed ID: 7178422
    [No Abstract]   [Full Text] [Related]  

  • 15. Comments on "Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb" by D.J. Brenner (Radiat. Res. 145, 501-507, 1996).
    Schmid E; Bauchinger M
    Radiat Res; 1996 Oct; 146(4):479-82. PubMed ID: 8927721
    [No Abstract]   [Full Text] [Related]  

  • 16. (41)Ca in Tooth Enamel. Part II: A means for retrospective biological neutron dosimetry in atomic bomb survivors.
    Rühm W; Wallner A; Cullings H; Egbert SD; El-Faramawy N; Faestermann T; Kaul D; Knie K; Korschinek G; Nakamura N; Roberts J; Rugel G
    Radiat Res; 2010 Aug; 174(2):146-54. PubMed ID: 20681781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.
    Sasaki MS; Endo S; Hoshi M; Nomura T
    J Radiat Res; 2016 Nov; 57(6):583-595. PubMed ID: 27614201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-banding analysis of radiation-induced chromosome damage in lymphocytes of Hiroshima A-bomb survivors.
    Ohtaki K
    Jpn J Hum Genet; 1992 Dec; 37(4):245-62. PubMed ID: 1297446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic validation of DS02R1-estimated dose for atomic bomb survivors in Hiroshima and Nagasaki with FISH.
    Kodama Y; Nakamura N; Nakano M; Ohtaki K; Hamasaki K; Noda A
    Int J Radiat Biol; 2024; 100(8):1155-1164. PubMed ID: 38991111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutron versus gamma-ray risk estimates. Inferences from the cancer incidence and mortality data in Hiroshima.
    Kellerer AM; Nekolla E
    Radiat Environ Biophys; 1997 Jun; 36(2):73-83. PubMed ID: 9271794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.